Anesthesia Tumescent for Surgical Management of Tenosynovitis.
Tenosynovitis
About this trial
This is an interventional treatment trial for Tenosynovitis focused on measuring Tumescent anesthesia, tenosynovitis, Visual Analog Scale, Tourniquets, Epinephrine
Eligibility Criteria
Inclusion Criteria:
- Right holders of the Mexican Social Security Institute
- Over 18 years
- Trigger Finger Diagnosis
- Diagnosis of Carpal Tunnel Syndrome
- Diagnosis of Quervain Syndrome
- Acceptance and signature of informed consent
Exclusion Criteria:
- Necessity for concomitant surgery
- Previous surgeries on the injured site
- Hemodynamic instability
- History of peripheral vascular diseases
- Do not wish to participate in the study
- Hypersensitivity to medication
- Smoking
Sites / Locations
- Western Medical Center, Mexican Institute of Social Security
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Tumescent anesthesia
Local anesthesia with tourniquet.
A tumescent solution was prepared; consisting of 40 cc of 0.9% Saline Solution, 10 cc of 2% Lidocaine, 0.4 cc of Epinephrine (1: 1000) and 4 cc of 7.5% Sodium Bicarbonate. This solution was applied in the incision sites according to the diagnosis and the proposed procedure. In case of trigger finger, 3 cc was applied subcutaneously in the proximal palmar crease of the affected finger; for Quervain syndrome, 5 to 6 cc of tumescent solution was injected along the first extensor compartment at the radial styloid level; and in the case of Carpal Tunnel Syndrome, 10 cc of tumescent solution was infiltrated on the flexor retinaculum in the subcutaneous tissue and from 7 to 10 cc below it. Subsequently, 20 minutes were waited for the epinephrine to cause vasoconstriction, and the asepsis of the limb was continued , sterile fields were placed, the incision site was corroborated and the surgical procedure proposed for each pathology was started.
Lidocaine 1% was applied to the incision sites according to the diagnosis and the proposed procedure. In case of trigger finger, 3 cc was applied subcutaneously in the proximal palmar crease of the affected finger; for Quervain syndrome, 5 to 6 cc were injected along the first extensor compartment at the radial styloid level; and in the case of Carpal Tunnel Syndrome, 10 cc was infiltrated on the flexor retinaculum in the subcutaneous tissue and from 7 to 10 cc below it. Afterwards, a pneumatic tourniquet was placed at the level of the forearm at 250 mmHg after exsanguination with a bandage from Esmarch. The asepsis of the limb was continued, sterile fields were placed, the incision site was corroborated and the surgical procedure proposed for each pathology was started. At the end of the surgical procedure, it was closed by planes, a soft bandage was placed, the tourniquet was removed and the patient was taken to recovery.